Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Arm, Open-Label, Standard of Care Control Evaluation of Ferric Citrate for the Transition From Chronic Kidney Disease Stage 4/5 to Chronic Kidney Stage 5D

NCT02492620 is registered in ClinicalTrials.gov with Denver Nephrologists, P.C. as lead sponsor.

NCT NCT02492620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02492620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Arm, Open-Label, Standard of Care Control Evaluation of Ferric Citrate for the Transition From Chronic Kidney Disease Stage 4/5 to Chronic Kidney Stage 5D
Lead sponsor
Denver Nephrologists, P.C.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2015
Completion date
November 30, 2017
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, hyperphosphatemia, iron deficiency anemia, renal insufficiency